Could cause temporary or reversible harm; serious harm is unlikely.
Failed Dissolution Specifications: This recall is being initiated in support of the recall by the manufacturer which included lots that were packaged for BluePoint Laboratories.
| Brand name | METOPROLOL SUCCINATE |
| Generic name | METOPROLOL SUCCINATE ER TABLETS |
| Active ingredient(s) | METOPROLOL SUCCINATE |
| Distributed by / for | Amerisource Health Services LLC |
| NDC | 68001-501-00 |
| Full product label | Metoprolol Succinate Extended-Release Tablets, USP, 50 mg, packaged in (a) 100-count bottle, NDC 68001-501-00; (b) 500-count bottle, NDC 68001-501-03. Manufactured by Alkem Laboratories Ltd., India. For BluePoint Laboratories |
| Recalling firm | Amerisource Health Services LLC |
| Distribution | Nationwide USA |
| Quantity | (a) 6670 100-count (b) 2666 500-count bottles |
| Recall initiated | 2023-01-11 |
| Report date | 2023-02-22 |
| Recall completed | 2024-05-12 |
| Recall number | D-0269-2023 |
| Classification | Class II |
| FDA status | Terminated |
| Origin on file | Columbus OH United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗